What is ChronWell?
Founded in 2017 by the architects of a leading US Gastroenterology IT platform, ChronWell aims to transform the Workers Compensation landscape. The company has developed a sophisticated platform designed to meticulously track an injury's journey from the initial incident through to the employee's return to work. This innovative approach has facilitated a groundbreaking Early Intervention program, demonstrably reducing costs, enhancing injury tracking, and ensuring appropriate reporting. Recognizing the broader applicability of its technology, ChronWell has expanded its vision to address the management of expensive chronic conditions beyond traditional medical practices, aligning with new Medicare-approved care management opportunities.
How much funding has ChronWell raised?
ChronWell has raised a total of $8.9M across 3 funding rounds:
Series A
$2.8M
Debt
$150K
Unspecified
$6M
Series A (2019): $2.8M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Unspecified (2021): $6M, investors not publicly disclosed
Key Investors in ChronWell
PPP
Public-Private Partnership
What's next for ChronWell?
The substantial enterprise-level funding indicates ChronWell is poised for significant scaling and market penetration. This capital injection will likely fuel further development of its platform, expansion into new healthcare verticals, and enhancement of its early intervention and chronic care management capabilities. The strategic nature of the recent investment suggests strong confidence from backers in ChronWell's long-term vision and its capacity to disrupt established healthcare IT markets, particularly within the Workers Compensation and chronic disease management sectors.
See full ChronWell company page
